Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RRAD and GEM like GTPase 2 | 1.1E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||||
|
cleavage stimulation factor subunit 2 tau variant | 8.6E-02 |
|
phenotype | 0.020 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||||
|
zinc finger protein 385A | 0.28 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||||
|
proteasome 26S subunit, ATPase, 6 pseudogene 1 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | |||||||||||
|
small nucleolar RNA, C/D box 50A |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||||
|
testis specific serine kinase 4 | 5.5E-09 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||||
|
solute carrier family 25 member 5 pseudogene 8 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | |||||||||||
|
myristoylated alanine rich protein kinase C substrate pseudogene 1 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | |||||||||||
|
deafness, autosomal recessive 45 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||||
|
taste 2 receptor member 9 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||||
|
villin like | 3.9E-23 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||||
|
preeclampsia/eclampsia 1 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | |||||||||||
|
ER membrane protein complex subunit 7 | 0.87 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||||
|
pro-platelet basic protein pseudogene 1 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||||
|
Breast cancer, 11;22 translocation associated |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | |||||||||||
|
deafness, autosomal dominant 18 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | |||||||||||
|
MYCBP associated and testis expressed 1 | 1.6E-13 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||||
|
elastin microfibril interfacer 3 | 9.2E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.700 | None | 0.975 | 24 | 0 | 1989 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.400 | None | 1.000 | 19 | 0 | 2002 | 2008 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.500 | None | 0.978 | 14 | 0 | 1990 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.600 | None | 1.000 | 11 | 0 | 2001 | 2016 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 0.950 | 8 | 0 | 1996 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.300 | None | 0.880 | 8 | 0 | 1990 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 0.906 | 8 | 0 | 1997 | 2020 |